MedPath

Fentanyl

Generic Name
Fentanyl
Brand Names
Abstral, Actiq, Duragesic, Effentora, Fentora, Instanyl, Lazanda, Sublimaze, Subsys, PecFent
Drug Type
Small Molecule
Chemical Formula
C22H28N2O
CAS Number
437-38-7
Unique Ingredient Identifier
UF599785JZ
Background

Fentanyl, a potent opioid agonist, was developed in the 1950s to fill a need for strong and rapid analgesia. Because of these characteristics, fentanyl is commonly used to treat chronic cancer pain or in anesthesia. Fentanyl is related to other opioids like morphine and oxycodone.

Fentanyl's high potency has also made it a common adulterant in illicit drugs, especially heroin. In 2017, 47600 overdose deaths in the United States involved some opioid (over 2/3 of all overdose deaths). Opioid overdoses kill an average of 11 Canadians daily.

Fentanyl was FDA approved in 1968.

Indication

Fentanyl intravenous or intramuscular injections are indicated for short term analgesia during induction, maintenance, and recovery from general or regional anesthesia. These injections are also used with a neuroleptic for premedication, induction, and as an adjunct to maintenance of anesthesia. Finally, fentanyl intravenous or intramuscular injections are used with oxygen for anesthesia in high risk patients.

Fentanyl sublingual tablets, transmucosal lozenges, buccal tablets, sublingual sprays, transdermal systems, and nasal sprays are indicated for the management of breakthrough pain in opioid tolerant cancer patients who require around the clock pain management.

Associated Conditions
Cancer Related Pain (Breakthrough Pain), Severe, Chronic Pain
Associated Therapies
Anesthetic premedication therapy, Anesthetics Agent, General Anesthesia, Induction of anesthesia therapy, Maintenance of anesthesia therapy, Regional Anesthesia therapy
Clinical Trials
Related News

Effects of Dexmedetomidine Sedation on Delirium and Haemodynamic in Mechanical Ventilated Elderly Patients

Phase 4
Conditions
Safety of Dexmedetomidine Sedation
Interventions
Drug: Dexmedetomidine
Drug: Midazolam
Drug: Fentanyl
First Posted Date
2014-08-26
Last Posted Date
2014-08-26
Lead Sponsor
Fuling Central Hospital of Chongqing City
Target Recruit Count
80
Registration Number
NCT02225210

Prevention of Propofol Injection Pain

Phase 2
Completed
Conditions
Pain
Interventions
Drug: saline
Drug: fentanyl
Drug: propofol
First Posted Date
2014-07-29
Last Posted Date
2014-09-25
Lead Sponsor
Yeditepe University Hospital
Target Recruit Count
150
Registration Number
NCT02203175
Locations
🇹🇷

Yeditepe University Hospital, Istanbul, Devlet Yolu, Ankara cad 102/104, Kozyatagi, Turkey

Study of Sedative Medications in Patients With Severe Infection and Respiratory Failure

Phase 4
Completed
Conditions
Agitation
Sepsis
Respiratory Failure
Interventions
Drug: Propofol
Drug: Dexmedetomidine
Drug: Fentanyl
First Posted Date
2014-07-29
Last Posted Date
2020-03-02
Lead Sponsor
Texas Tech University Health Sciences Center
Target Recruit Count
36
Registration Number
NCT02203019
Locations
🇺🇸

University Medical Center, Lubbock, Texas, United States

Effect of Induction and Maintenance of Anesthesia With Etomidate on Hemodynamics and Oxidative Stress in Diabetic Patients

Phase 4
Conditions
Oxidative Stress
Hemodynamics
Anesthesia
Interventions
Drug: midazolam
Drug: Penehyclidine Hydrochloride Injection
Drug: Propofol
Drug: Etomidate
Drug: Fentanyl
Drug: Cisatracurium Besilate
Drug: Remifentanil
Drug: Sevoflurane
First Posted Date
2014-07-28
Last Posted Date
2014-07-28
Lead Sponsor
Zhujiang Hospital
Target Recruit Count
60
Registration Number
NCT02202239

Awakening in Spine Surgery: A Comparison Between Clinical Signs and Bispectral Index

Not Applicable
Completed
Conditions
Spine Diseases
Interventions
Drug: Target controlled infusion of propofol
Device: bispectral index
Drug: Fentanyl
Drug: Atracurium
First Posted Date
2014-06-26
Last Posted Date
2020-07-13
Lead Sponsor
Mahidol University
Target Recruit Count
34
Registration Number
NCT02174913
Locations
🇹🇭

Mahidol University, siriraj hospital, Bangkok, Thailand

Optimizing Dose of Bupivacaine in Combined Spinal Epidurals To Reduce Side Effects

Not Applicable
Completed
Conditions
Pregnancy
Interventions
Drug: Bupivacaine
Drug: Fentanyl
First Posted Date
2014-06-10
Last Posted Date
2019-01-03
Lead Sponsor
St. Luke's-Roosevelt Hospital Center
Target Recruit Count
170
Registration Number
NCT02159807
Locations
🇺🇸

Roosevelt hospital, New York, New York, United States

Dexmedetomidine-ketamine in Femur Proximal Fracture Patients

Not Applicable
Completed
Conditions
Pain
Interventions
Drug: Dexmedetomidine
Drug: Ketamine
Drug: Fentanyl
First Posted Date
2014-05-30
Last Posted Date
2019-04-29
Lead Sponsor
Inje University
Target Recruit Count
46
Registration Number
NCT02150759
Locations
🇰🇷

Haeundae paik hospital, inje university, Busan, Korea, Republic of

Opioid vs. Opioid-free Anesthesia for Hip Arthroscopy

Phase 3
Terminated
Conditions
Opioid Free Anaesthesia
Postoperative Analgesia
Interventions
Drug: Lidocaine/ ketamine
Drug: Fentanyl
First Posted Date
2014-05-29
Last Posted Date
2015-09-25
Lead Sponsor
Clinica Santa Maria
Target Recruit Count
53
Registration Number
NCT02150161
Locations
🇨🇱

Clinica Santa Maria, Santiago, Chile

Post Operative Pain Control: Morphine vs Fentanyl

Not Applicable
Completed
Conditions
Post Operative Analgesia
Interventions
Drug: Morphine
Drug: Fentanyl
First Posted Date
2014-05-26
Last Posted Date
2014-05-26
Lead Sponsor
Catholic University of the Sacred Heart
Target Recruit Count
60
Registration Number
NCT02146638
Locations
🇮🇹

catholic University of the sacred Heart, Rome, Italy

Efficacy of Fentanyl to Reduce the Time of Severe Postoperative Pain Relief Compared to Morphine

Phase 3
Completed
Conditions
Postoperative Pain
Interventions
Drug: Fentanyl
Drug: Morphine
First Posted Date
2014-05-23
Last Posted Date
2014-05-23
Lead Sponsor
Universidad de Antioquia
Target Recruit Count
60
Registration Number
NCT02145975
Locations
🇨🇴

Antioquia University, Medellin, Antioquia, Colombia

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy